IP Library Granted Patent US 7,955,844
Granted Patent B2
US 7,955,844 · App. 12/398,352 · Granted Jun 7, 2011

Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals

Assignee: Stanford University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,955,844
App. No.
12/398,352
Granted
Jun 7, 2011
Kind
B2
Abstract

Novel double and triple fusion reporter gene constructs harboring distinct imagable reporter genes are provided, as well as applications for the use of such double and triple fusion constructs in living cells and in living animals using distinct imaging technologies.

Claims (21)

1. A noninvasive method for detecting the level of expression of a gene of interest in an animal using multimodality imaging, comprising:

(a) administering a triple fusion vector to the animal, wherein the triple fusion nucleic acid expression vector comprises a first reporter nucleic acid sequence, a second reporter nucleic acid sequence, a third reporter nucleic acid sequence, a first nucleic acid linker sequence, and a second nucleic acid linker sequence, wherein:

(i) the first reporter nucleic acid sequence, the second reporter nucleic acid sequence, the third reporter nucleic acid sequence, the first nucleic acid linker sequence, and the second nucleic acid linker sequence are operably linked to an expression control system and co-expressible as a single fusion polypeptide therefrom;

(ii) the first reporter nucleic acid sequence and the second reporter nucleic acid sequence are separated from each other by the first nucleic acid linker sequence;

(iii) the second reporter nucleic acid sequence and the third reporter nucleic acid sequence are separated from each other by the second nucleic acid linker sequence;

(iii) each of the first, second, and third reporter nucleic acid sequences encodes an individual imageable reporter region of the expressed fusion polypeptide;

(iv) each of the individual imageable reporter regions of the fusion polypeptide is imageable by a method selected from the group consisting of: detecting bioluminescence, detecting fluorescence, and positron emission topography, wherein no two reporter regions are imageable by the same method; and

(v) the first nucleic acid linker sequence encodes a first polypeptide linker having the amino acid sequence SEQ ID NO: 9, and the second nucleic acid linker sequence encodes a second polypeptide linker having the amino acid sequence SEQ ID NO: 10;

(b) administering coelenterazine to the animal;

(c) immobilizing the animal within the detection field of a photodetection device;

(d) measuring the level of bioluminescent light emission in the animal with the photodetection device;

(e) measuring the level of fluorescent light emission in the animal with the photodetection device; and

(f) immobilizing the animal within the detection field of a PET device, and measuring the level of positron emission.

2. The method according to claim 1 , wherein the nucleic acid sequence encoding the imageable reporter region of the fusion polypeptide that is imageable by positron emission topography encodes herpes simplex virus type 1 sr39 thymidine kinase (HSVI-sr39 thymidine kinase).

3. The method according to claim 1 , wherein the first nucleic acid encodes wild type HSVI thymidine kinase.

4. The method according to claim 1 , wherein the first nucleic acid encodes a bioluminescent polypeptide.

5. The method according to claim 4 , wherein the first nucleic acid encodes renilla luciferase.

6. The method according to claim 4 , wherein the first nucleic acid encodes firefly luciferase.

7. The method according to claim 1 , wherein the first nucleic acid encodes a fluorescence polypeptide.

8. The method according to claim 7 , wherein the first nucleic acid encodes red fluorescence protein.

9. The method according to claim 7 , wherein the first nucleic acid encodes green fluorescence protein.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 8, 2010
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025111/0723 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2009
From: GAMBHIR, SANJIV; PRITHA, RAY
To: STANFORD UNIVERSITY
Reel/Frame 022349/0539 →
Continuity (3)
Division 10548146
Provisional Application 60452913 · Mar 7, 2003
Related Publication 20090208419A1 · Aug 20, 2009